Pros | Among most bought funds within the category. Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 5Y returns in the bottom 25% of the category. | - |
INDMoney rank | 7/8 | 4/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 11 Years | 11 Years | ||
Fund Size | 8638 Cr | 3460 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹5000 | SIP ₹500 Lumpsum ₹5000 | ||
Expense Ratio | 0.91% | 0.89% | ||
Exit Load | 1% | 0.5% | ||
Benchmark Index | S&P BSE Healthcare PR | S&P BSE Healthcare PR |
No of Holdings | 36 | 29 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (13.95%) Divi's Laboratories Ltd (9.16%) Lupin Ltd (8.06%) Cipla Ltd (5.54%) Apollo Hospitals Enterprise Ltd (5.24%) | Sun Pharmaceuticals Industries Ltd (12.99%) Max Healthcare Institute Ltd Ordinary Shares (6.26%) Divi's Laboratories Ltd (6.21%) Poly Medicure Ltd (5.38%) Lupin Ltd (5.12%) | ||
No of Sectors | 1 | 2 | ||
Top 3 Sectors | Health (100%) | Health (93.24%) Basic Materials (6.76%) | ||
Equity % | 95.57% | 96.74% | ||
Debt % | - | - | ||
P/E | 39.15 | 45.23 | ||
P/B | 6.61 | 6.43 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.26% | 1.29% | ||
3-Month Return | -1.87% | 3.45% | ||
6-Month Return | 14.28% | 22.84% | ||
1-Year Return | 38.09% | 48.33% | ||
3-Year Return | 20.86% | 26.14% | ||
5-Year Return | 29.16% | 31.36% |
Sharpe | 0.89 | 1.21 | ||
Alpha | 0.57 | 5.11 | ||
Beta | 0.92 | 0.87 | ||
Standard Deviation | 15.15 | 14.34 | ||
Information Ratio | -0.12 | 1.09 |
Description | Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund.The fund could potentially beat inflation in the long-run. | SBI Healthcare Opportunities Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Kinjal Desai,Sailesh Raj Bhan | Tanmaya Desai |